CN1149205C - 多环的噻唑体系和它们作为减食欲剂的用途 - Google Patents

多环的噻唑体系和它们作为减食欲剂的用途 Download PDF

Info

Publication number
CN1149205C
CN1149205C CNB008042365A CN00804236A CN1149205C CN 1149205 C CN1149205 C CN 1149205C CN B008042365 A CNB008042365 A CN B008042365A CN 00804236 A CN00804236 A CN 00804236A CN 1149205 C CN1149205 C CN 1149205C
Authority
CN
China
Prior art keywords
alkyl
acid
phenyl
compound
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008042365A
Other languages
English (en)
Chinese (zh)
Other versions
CN1341108A (zh
Inventor
G
G·杰恩
K·盖森
H－J·兰格
M·毕克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of CN1341108A publication Critical patent/CN1341108A/zh
Application granted granted Critical
Publication of CN1149205C publication Critical patent/CN1149205C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB008042365A 1999-02-26 2000-02-05 多环的噻唑体系和它们作为减食欲剂的用途 Expired - Fee Related CN1149205C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908533.1 1999-02-26
DE19908533A DE19908533A1 (de) 1999-02-26 1999-02-26 Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen

Publications (2)

Publication Number Publication Date
CN1341108A CN1341108A (zh) 2002-03-20
CN1149205C true CN1149205C (zh) 2004-05-12

Family

ID=7899078

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008042365A Expired - Fee Related CN1149205C (zh) 1999-02-26 2000-02-05 多环的噻唑体系和它们作为减食欲剂的用途

Country Status (19)

Country Link
US (1) US6187801B1 (https=)
EP (1) EP1183247B1 (https=)
JP (1) JP4728485B2 (https=)
KR (1) KR20020000545A (https=)
CN (1) CN1149205C (https=)
AT (1) ATE296295T1 (https=)
AU (1) AU762802B2 (https=)
BR (1) BR0008511A (https=)
CA (1) CA2364903A1 (https=)
CO (1) CO5180595A1 (https=)
DE (2) DE19908533A1 (https=)
DK (1) DK1183247T3 (https=)
ES (1) ES2241574T3 (https=)
HK (1) HK1042300B (https=)
MY (1) MY133195A (https=)
PT (1) PT1183247E (https=)
TW (1) TW593294B (https=)
WO (1) WO2000051997A1 (https=)
ZA (1) ZA200106440B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
KR100763214B1 (ko) * 2000-02-26 2007-10-08 사노피-아벤티스 도이칠란트 게엠베하 2 위치에서 설폰아미도 또는 설포노 치환체를 갖는 8,8ａ-디하이드로-인데노[1,2-ｄ]티아졸 유도체, 이의 제조방법 및 이를 포함하는 약제
DE10142663B4 (de) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-ol-Systeme
KR100712171B1 (ko) * 2004-09-17 2007-05-02 김진우 폐타이어를 이용한 조립식 배관블록
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
ES2558742T3 (es) 2009-09-28 2016-02-08 F. Hoffmann-La Roche Ag Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
ES2570569T3 (es) 2009-09-28 2016-05-19 Hoffmann La Roche Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
WO2012126901A1 (en) 2011-03-21 2012-09-27 F. Hoffmann-La Roche Ag Benzoxazepin compounds selective for pi3k p110 delta and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
NZ281718A (en) * 1994-03-11 1997-08-22 Yamanouchi Pharma Co Ltd Heterocyclically-substituted (condensed) thiazoles
JPH1179993A (ja) * 1997-09-05 1999-03-23 Sumitomo Pharmaceut Co Ltd 免疫抑制剤
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Also Published As

Publication number Publication date
JP2002538150A (ja) 2002-11-12
BR0008511A (pt) 2002-04-02
EP1183247B1 (de) 2005-05-25
DE50010403D1 (de) 2005-06-30
AU2441600A (en) 2000-09-21
ES2241574T3 (es) 2005-11-01
HK1042300A1 (en) 2002-08-09
KR20020000545A (ko) 2002-01-05
CA2364903A1 (en) 2000-09-08
DE19908533A1 (de) 2000-08-31
CN1341108A (zh) 2002-03-20
PT1183247E (pt) 2005-07-29
AU762802B2 (en) 2003-07-03
MY133195A (en) 2007-10-31
ATE296295T1 (de) 2005-06-15
JP4728485B2 (ja) 2011-07-20
ZA200106440B (en) 2002-03-06
WO2000051997A1 (de) 2000-09-08
TW593294B (en) 2004-06-21
DK1183247T3 (da) 2005-09-19
HK1042300B (zh) 2004-12-10
CO5180595A1 (es) 2002-07-30
EP1183247A1 (de) 2002-03-06
US6187801B1 (en) 2001-02-13

Similar Documents

Publication Publication Date Title
CN1173959C (zh) 在2 －位携带具有磺酰胺结构或砜结构的取代基的8, 8a －二氢茚并 [1,2－d ]噻唑衍生物、它们的制备方法和它们作为药物的用途
CN1384827A (zh) 茚并一,萘并一和苯并环庚二氢噻唑衍生物,它们的制备以及它们作为降低食欲药的用途
CN1141940C (zh) 多环噻唑体系用于制备预防或治疗肥胖的药物的用途
CN1148362C (zh) 多环的2-氨基噻唑体系、它们的制备方法和包含这些化合物的药物
CN1149205C (zh) 多环的噻唑体系和它们作为减食欲剂的用途
RU2236405C2 (ru) Полициклические тиазолидин-2-илиденовые амины, содержащие их лекарственные средства и способ получения лекарственного средства
CN1161120C (zh) 多环2-氨基噻唑体系在预防或治疗肥胖的药物制备中的用途
CN1152026C (zh) 多环的2-氨基二氢噻唑体系、它们的制备方法和它们作为药物的用途
CN1152027C (zh) 多环的噻唑-2-亚基胺、它们的制备方法和它们在制备药物中的用途
CN1159306C (zh) 取代的8,8a-二氢-3aH-茚并[1,2-d]噻唑、它们的制备方法和它们作为药物的用途
HK1055117B (en) 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, a method for their production and their use as medicaments
HK1055117A1 (en) 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, a method for their production and their use as medicaments
MXPA01007494A (en) Polycyclic thiazole systems and their utilization as anorectics
HK1044766A (en) Polycyclic 2-aminodihydrothiazole systems, processes for their preparation and their use as pharmaceuticals
HK1050524B (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
MXPA01007542A (es) Uso de sistemas de tiazol policiclico para producir medicamentos para prevenir o tratar obesidad

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee